MTOR and neoplasm: These findings suggest that [177Lu]Lu-DOTA-CCK2R-dimer may alleviate the oxidative stress burden in tumor cells by activating radiotherapy-related detoxification pathways, whereas the addition of an mTOR inhibitor may increase therapeutic efficacy by suppressing these pathways, thus increasing the susceptibility of tumor cells to oxidative damage.